CTRI/2023/03/050483尚未招募Unknown
Antiphospholipid Syndrome in Pre-eclampsia with severe features and fetal growth restriction.
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Singleton pregnancy
- •women delivered at or before 36 weeks gestation
- •Preeclampsia with severe features and/or
- •Fetal growth restriction due to placental Insufficiency.
排除标准
- •Multiple gestations
研究者
相似试验
已完成
不适用
Antiphospholipid syndrome in pregnancy: A controlled treatment trialPregnancyantiphospholipid antibody syndromePregnancy and ChildbirthOther maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperiumISRCTN55179279HS R&D Regional Programme Register - Department of Health (UK)98
Unknown
不适用
Antiphospholipid Antibodies and Early Severe Preeclampsia.Severe PreeclampsiaAntiphospholipid SyndromeNCT01538121Saint Thomas Hospital, Panama310
进行中（未招募）
不适用
Antiphospholipid antibodies testing and pregnancy outcomes in recurrent implantation failure women, is it necessary?Recurrent implantation failure womenRecurrent implantation failureAntiphospholipid antibodiesICSITCTR20231003007/A250
已完成
1 期
Treating early onset severe preeclampsia with pravastatin: an early phase clinical trialPreeclampsiaReproductive Health and Childbirth - Fetal medicine and complications of pregnancyReproductive Health and Childbirth - Antenatal careACTRN12613000268741The Mercy Hospital for Women12
Unknown
不适用
Antiphospholipid Antibodies and Fetal Growth RestrictionAntiphospholipid SyndromeFetal Growth RestrictionNCT01538134Saint Thomas Hospital, Panama90